Agfa HealthCare implementing additional price increases of up to 70% on medical film

Tue May 3, 2011 1:46am EDT

* Reuters is not responsible for the content in this press release.

New prices effective immediately


Mortsel, Belgium - May 3, 2011 - 07:45 a.m. CET


The price of silver, a key ingredient of medical film, has tripled over the last 14 months, and has reached levels unseen in 30 years. It is evident that this price increase goes beyond the efficiency gains that any industry can reasonably achieve. We therefore have to further increase prices of medical film.


Agfa-Gevaert Press contacts:
Viviane Dictus
Director Corporate Communication
T +32 3 444 7124


Johan Jacobs
Corporate Press Relations Manager
T +32 3 444 8015


Geertrui De Smet
Global PR Manager Agfa HealthCare
T +32 (0)3 444 73 06



About Agfa
The Agfa-Gevaert Group is one of the world's leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,948 million euro in 2010.


About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions.  The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's.  Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2010 were 1,180 million euro.  For more information on Agfa HealthCare, please visit



Agfa and the Agfa rhombus are trademarks of Agfa-Gevaert N.V. Belgium or its affiliates.  All rights reserved.


All information contained herein is intended for guidance purposes only, and characteristics of the products and services described in this publication can be changed at any time without notice. Products and services may not be available for your local area. Please contact your local sales representative for availability information. Agfa HealthCare diligently strives to provide as accurate information as possible, but shall not be responsible for any typographical error.

Only the English version of this press release is legally valid.  The versions in other languages only represent a translation of the original English version.


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Agfa-Gevaert via Thomson Reuters ONE